US surgeons perform world's first bladder transplant
Surgeons at a hospital in Los Angeles, California have successfully performed the world's first human bladder transplant, hospital officials said.
The surgery, performed May 4 at Ronald Reagan UCLA Medical Centre, is a promising development for other patients suffering from serious bladder disorders.
The recipient of the innovative procedure was Oscar Larrainzar, 41, a father of four who had a large portion of his bladder removed due to cancer several years ago, the University of California, Los Angeles, said in a statement Sunday.
Larrainzar later had both of his kidneys removed due to cancer and end-stage kidney disease and was on dialysis for seven years.
He received both a bladder and a kidney from an organ donor and had them successfully transplanted in an eight-hour operation.
"The surgeons first transplanted the kidney, followed by the bladder; they then connected the kidney to the new bladder using the technique they had pioneered," the UCLA statement said.
Dr. Nima Nassiri, one of the surgeons involved in the historic transplant, said the procedure yielded positive results almost instantaneously.
"The kidney immediately made a large volume of urine, and the patient's kidney function improved immediately," Nassiri said.
"There was no need for any dialysis after surgery, and the urine drained properly into the new bladder."
Nassiri and fellow surgeon Inderbir Gill said full bladder transplants had not been performed previously due to the complex vascular structure of the pelvis, making it a technically difficult procedure.
"This first attempt at bladder transplantation has been over four years in the making," Nassiri said.
Previously, patients in need of bladder reconstruction could have one artificially created using a part of the intestines or have a stoma bag inserted to collect urine.
Those techniques had several short-term and long-term risks that doctors hope will be circumvented with the full bladder transplant, Nassiri said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Khaleej Times
8 hours ago
- Khaleej Times
Are stem cell therapies are safe to try to fight diseases?
The promise of stem cell therapy is powerful. Scientists can draw versatile cells from the human body and deliver them to repair injuries and fight disease from the inside out. But not all stem cell therapies are created equal. Some, like bone marrow transplants, are supported by decades of clinical research and are considered safe and effective. Others are still in clinical trials, meaning they're promising concepts but have not yet been put into practice. At the same time, medical spas and longevity clinics are increasingly marketing their own stem cell treatments for arthritis, joint pain, Parkinson's disease, A.L.S. and even better skin. Scientists warn that the treatments being touted by these spas and clinics are all unproven, expensive and could come with dangerous side effects. 'This clinic industry poses all kinds of risks to the public,' said Paul Knoepfler, a professor at the University of California Davis School of Medicine who studies stem cells. Some stem cell experts, including Dr. Knoepfler, are worried that the F.D.A. may loosen oversight on stem cell therapy, which could confuse the public about the difference between scientifically supported treatment and untested therapies. Their concerns come in part from Health Secretary Robert F. Kennedy Jr.'s remarks on the subject, including a post on X in October calling for an end to the F.D.A.'s 'aggressive suppression' of stem cell therapies. During a recent podcast with longevity influencer Gary Brecka, Mr. Kennedy said that he had traveled to Antigua to get a stem cell treatment for his throat. Mr. Kennedy, who has a neurological condition that affects his throat and voice, said the therapy helped him 'enormously.' 'Why did I have to go to Antigua for that?' he said, suggesting that he would work to expand access to stem cell treatments and other experimental therapies. How are stem cells regulated right now? Companies developing stem cell therapies can apply to the Food and Drug Administration for authorization to begin studies in humans. If the therapy appears to work, the company can then seek approval from the F.D.A., which reviews the data on the treatment. In addition, F.D.A. has the power to regulate the products offered at private clinics, which have generally not been approved. The agency has previously demanded some clinics stop selling unproven stem cell treatments that could harm patients or cause them to delay more legitimate treatment. Less regulation, though, may mean less oversight of companies 'charging a lot of money for something that's not really been validated,' said Clive Svendsen, a professor of biomedical sciences who leads a stem cell research lab at Cedars-Sinai in Los Angeles. Why are scientists excited about them? Stem cells are the blank cells that all tissues and organs in your body are created from. Unlike many other cells, certain stem cells can also regenerate. Because of that, scientists think they could offer an endless supply of cells that can be manipulated to replace other types of cells in your body that have been damaged. Some treatments rely on adult stem cells harvested from blood or bone marrow. Others use regular skin or blood cells which are reprogrammed into stem cells in a lab. For approved therapies, these stem cells are typically manipulated in a lab to become a certain type of cell, and then delivered into specific tissues in the hopes that they replace lost or injured cells, said Tenneille Ludwig, director of the WiCell Stem Cell Bank in Wisconsin, which distributes cells used in research and clinical trials. What treatments are available and what's being studied? Only a handful of stem cell therapies are currently approved by the F.D.A., mainly for treating blood cancer and immune system disorders. (Some therapies, for conditions like corneal damage or arterial disease, are approved in other countries but not in the United States.) In bone marrow transplants, one of the F.D.A.-approved treatments, a donor's stem cells are injected into a patient, where they become blood or immune cells that can replace the ones damaged by chemotherapy or radiation treatment. One ongoing clinical trial is investigating whether stem cells can replace the dopamine-producing neurons that die out during Parkinson's disease, which could potentially reverse the symptoms. Another is looking at whether insulin-producing cells derived from stem cells can be used as a diabetes treatment. And there's other research that some scientists see as promising. Studies have suggested that stem cells that have been reprogrammed into blank cells and then into heart cells may be able to restore some cardiac function. Larger trials on neurological and cardiac treatments — including for A.L.S. and heart failure — are ongoing, but have so far fallen 'short of expectations,' said Jeffrey Karp, chair of the anesthesiology department at Mass General Brigham and Harvard Medical School. What about the experimental treatments at private clinics? Thousands of clinics around the country now offer what they claim are stem cell treatments for a wide range of diseases. These treatments are not covered by insurance, and can cost between a few thousand to tens of thousands of dollars per injection, Dr. Svendsen said. Typically, these clinics draw stem cells from the patients' body or a donor, sometimes from their fat, and inject them back into the patient without any manipulation, experts said. (This can allow companies to skirt the F.D.A., which does not regulate some stem cell treatments if providers say they are only minimally manipulating a person's own cells.) If these treatments do happen to offer some relief, 'it's very likely that it's a placebo,' Dr. Svendsen said, adding that there's no sound scientific explanation for why stem cells that haven't been manipulated into more specific cell types would offer any health benefits. 'They're just asking you for $7,000 to have your cells infused back into your body.' There are other risks to consider. First, there's no guarantee that clinics use true stem cells, Dr. Karp said: While they may be collecting cells from a patient or donor's bone marrow or fat, there's no assurance that the cells they collected are the ones that regenerate. Clinics also aren't required to report where the donor stem cells came from, which means they could be contaminated, Dr. Karp said. In addition, improper injections — and contaminated cells — could lead to serious health problems like clots or cells traveling to the wrong organs in the body, the experts said. The F.D.A. has previously warned of reports of blindness, tumor formations and infections after unapproved stem cell treatments. In 2017, three patients in Florida had permanent vision damage after stem cells were injected into their eyes in an attempt to treat macular degeneration. 'Of course you're going to get a lot of charlatans, and you're going to get people who have bad results,' Mr. Kennedy acknowledged on the recent podcast appearance. 'And ultimately, you can't prevent that either way.' Dr. Karp said that 'the most dangerous scenarios tend to occur at for-profit clinics operating without oversight.' 'These clinics often make exaggerated claims and skip crucial safety protocols,' he said. While people with chronic pain or other illness may be desperate for relief, these unproven treatments pose a 'serious possibility of injury,' Dr. Ludwig said, adding that patients should ask what regulatory protocols clinics follow, and the extent to which scientific literature supports their treatments. 'I would be very wary.'
Zawya
a day ago
- Zawya
IntelliDent AI and Manipal Academy of Higher Education sign strategic MoU to transform healthcare through AI
IntelliDent AI, a Dubai-based healthtech innovator transforming dentistry through artificial intelligence, has signed a Memorandum of Understanding (MoU) with the Manipal Academy of Higher Education (MAHE), India—an Institution of Eminence and global academic leader. This strategic three-year partnership aims to accelerate advancements in AI-powered oral healthcare through collaborative research, education, and entrepreneurship. The MoU, executed on behalf of MAHE's Manipal College of Dental Sciences (MCODS), Mangalore, lays the foundation for academic-industry cooperation focused on developing future-ready dental AI solutions and equipping students with the technical and entrepreneurial skills to lead the next era of digital healthcare. Key Pillars of the Collaboration: Joint Research Programs: MAHE and IntelliDent will co-develop research initiatives in AI-driven diagnostics, public health, and healthcare innovation—contributing to academic publications, patents, and whitepapers. Training & Internships: MAHE students will gain hands-on exposure through internships and mentorships at IntelliDent, supported by industry insights, guest lectures, and workshops. Entrepreneurial Development: The collaboration will foster cohort-based learning modules, innovation hackathons, and startup support to accelerate the commercialization of student-led healthtech ideas. Knowledge Exchange: Faculty, researchers, and industry experts will engage in reciprocal learning and cross-training to fuel innovation, skill-building, and strategic growth. Affaan Shaikh, Founder & CEO of IntelliDent AI, shared his thoughts on the collaboration: 'This partnership is about reimagining healthcare through ethical AI and innovation. We are thrilled to work alongside one of India's top institutions to shape the next generation of AI health leaders.' The MoU was signed by Dr. Giridhar P. Kini, Registrar of MAHE, and Mr. Affaan Shaikh, with active engagement from academic and innovation stakeholders from both organizations. This collaboration underscores IntelliDent AI's mission to scale accessible, AI-powered dental care globally and MAHE's continued commitment to integrating technology, research, and impact-driven education in the healthcare ecosystem. Together, MAHE and IntelliDent AI are building a bold future where education, innovation, and oral health equity intersect.
The National
2 days ago
- The National
'I want to run and play with my siblings': Palestinian-Jordanian girl hopes for new life after US surgery
For much of her childhood, Leen Mohammad has depended on a wheelchair and walker to move around. Born in Amman with cerebral palsy, the Palestinian-Jordanian girl has spent her life with limited mobility, often watching from the sidelines as other children run, jump and play. Now 12, Leen has travelled thousands of kilometres with her mother to Shriners Children's Hospital in Philadelphia, Pennsylvania, where doctors carried out complex, six-hour surgery on her legs, offering her a new chance at mobility. 'When I start walking, I will feel so happy,' Leen told The National. 'I want to play with my siblings. I want to run. I want to go shopping with my mother.' Leen suffers from spastic quadriplegia, a severe form of cerebral palsy affecting all four limbs. The family, originally from Jenin in the occupied West Bank, have travelled to the US for medical treatment three times. In 2016, when Leen was only four, she underwent surgery at Shriners Hospital in Minnesota to help her walk, with the procedure fully covered by the hospital due to the high cost of overseas care. Four years later, in 2020, Leen and her mother travelled to St Louis Children's Hospital in Missouri for a procedure known as selective dorsal rhizotomy (SDR), a form of neurosurgery that helps reduce spasticity, a condition that causes muscle stiffness and tightness. The treatment cost about $70,000, said Leen's mother Sana'a Shllak. With no medical insurance, the family raised the funds through a GoFundMe campaign and by creating and selling handmade frames inscribed with the word "hope". 'What she has going on now is actually very common in kids with spastic quadriplegia,' explained Dr Terrence Ishmael, paediatric orthopaedic and spine surgeon at Shriners in Philadelphia, who in May carried out Leen's third operation. 'When they have surgery at a really young age, often times the clinical scenario can change as they grow, because, you know, her body and her bones are growing really quickly, but often times, her muscles and her tendons don't quite grow at the same rate. "Sometimes the bones are not aligned in the position that is the most efficient for her to walk, so it's actually very common for originally treated issues to recur again.' Leen is approaching skeletal maturity, which means the likelihood of her needing more surgery is lower than it would have been at a younger age. 'The hope is that the results we get with this procedure, or this combination of procedures, will be durable and last year into adulthood,' the surgeon added. The family expressed deep gratitude to the hospital for covering the full cost of Leen's medical treatment. They also received crucial support from Heal Palestine, a non-profit organisation dedicated to helping Palestinian children rebuild their lives. 'Without Heal Palestine, the trip would not have been possible,' said Ms Shllak, who explained that the organisation funded their flights and accommodation in Philadelphia. Established on January 1 last year, Heal Palestine has been providing essential support to children affected by the Israel-Gaza war. Leen is the first Jordanian-Palestinian child the group has assisted. From struggle to strength 'It is heartbreaking. I feel lost, sad, but I need to be strong for her. I always Google about her case to choose the best for her,' said Ms Shllak. Leen was only nine months old when she fell into a six-day coma. It was then that doctors diagnosed her with cerebral palsy. For the first four years of Leen's life, Ms Shllak carried her everywhere, all while desperately searching the internet for treatment options. That's how she discovered Shriners Children's Hospital. 'The US offers more advanced treatment and equipment compared to Jordan and the doctors are experts. So I chose the US to treat my daughter," she said. Leen currently has casts on both legs, which will be removed six weeks after surgery. She and her mother are staying with a host family in the US state of Delaware and plan to return to Jordan in August. 'Once the casts come off, she'll be placed in new braces for her feet, and we expect that she'll be able to take her first steps with a walker right after having the cast removed,' said Dr Ishmael. Leen dreams of one day walking, and even running, without assistance. But given her condition, the doctor says it's difficult to predict whether she will ever be able to move entirely on her own. 'The treatment is ultimately to make her walk more efficiently, but in terms of her becoming an independent walker of any meaningful distance, it's unlikely because of her underlying condition,' said Dr Ishmael. He explained that Leen's voluntary motor control is significantly limited, affecting her upper and lower limbs. 'There are kids who have less severe cerebral palsy, who do achieve meaningful, independent ambulation with minimal assistance. But it's not clear as to whether or not Leen is one of those, and it's hard to predict,' he added. Despite the challenges, Leen's family remains determined to give her a more independent future. For them, this journey is about more than mobility - it's rooted in the belief that every child deserves the chance to thrive. As for Leen, no dream feels out of reach. 'When I grow up, I want to be a doctor so I can help kids like me,' she says with a smile.
